신규 정신건강 디바이스 및 플랫폼 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 용도별, 지역별 경쟁(2021-2031년)

The Global Emerging Mental Health Devices and Platforms Market is projected to expand significantly, growing from USD 4.37 Billion in 2025 to USD 12.67 Billion by 2031, at a compound annual growth rate (CAGR) of 19.41%. This sector encompasses a range of innovations, including digital therapeutics, wearable sensors for biometric tracking, and AI-powered telepsychiatry software designed to provide remote psychological support and continuous assessment. Key drivers fueling this market growth are the increasing global incidence of psychological disorders and a severe scarcity of qualified mental health professionals, which collectively demand scalable digital interventions to bridge existing care gaps. These factors are further bolstered by growing regulatory backing for remote patient monitoring and a transition towards value-based care models that prioritize accessibility and early intervention over traditional in-person therapies.However, the market faces considerable obstacles, primarily stemming from data privacy concerns and the intricate regulatory environment governing software as a medical device, which can impede product launches. Stringent compliance requirements related to patient data security represent a significant barrier for new developers seeking market entry. The World Health Organization reported that by 2025, tele-mental health services had expanded to over 60% of countries globally, underscoring a substantial infrastructural shift that providers must navigate alongside these complex regulatory challenges.

Market Driver

The escalating global prevalence of mental health disorders serves as the primary catalyst for the market, generating an urgent need for scalable and accessible therapeutic interventions that traditional in-person care models cannot adequately provide. As instances of anxiety and depression intensify, healthcare systems are increasingly adopting digital platforms to close the widening gap between patient demand and available providers. According to the '2025 State of Mental Health in America' report by Mental Health America in October 2025, 23.40% of U.S. adults experienced a mental illness in 2024, indicating a vast patient population requiring ongoing, remote support. This growing burden has directly accelerated the integration of virtual care technologies into standard clinical practice; the American Medical Association reported in December 2025 that 71.4% of physicians used telehealth platforms in 2024 for patient management, demonstrating the market's rapid expansion driven by this critical demand.Concurrently, advancements in Artificial Intelligence and Machine Learning are profoundly transforming the effectiveness and adoption of emerging mental health devices by evolving tools from mere passive monitoring to active clinical assistance. New algorithms are capable of analyzing intricate behavioral data to deliver real-time diagnostic insights, substantially enhancing the value proposition for mental health professionals who may have previously been hesitant to embrace digital solutions. This technological maturity is instigating a significant shift in clinical workflows; the American Psychological Association's '2025 Practitioner Pulse Survey' in December 2025 revealed that AI tool adoption among psychologists surged to 56% by late 2025, a marked increase from prior years. These innovations not only reduce administrative burdens but also empower providers to deliver personalized, data-driven interventions at scale, thereby cementing AI's foundational role in modern mental health infrastructure.

Market Challenge

The stringent regulatory environment and escalating data privacy concerns pose a significant impediment to the growth of the Global Emerging Mental Health Devices and Platforms Market. Developing software as a medical device (SaMD) necessitates navigating complex compliance standards, compelling companies to allocate substantial resources to legal and security infrastructure. This financial strain is particularly burdensome for innovators who, despite possessing valuable technology, may lack the resources to endure lengthy certification processes. Consequently, the time-to-market for new digital therapeutics is considerably prolonged, thereby decelerating the overall pace of innovation.Furthermore, reluctance among providers to integrate these platforms without absolute guarantees of security severely restricts market penetration. When mental health professionals perceive a risk of data breaches, their willingness to utilize digital interventions decreases. According to the American Medical Association in 2025, 87% of physicians emphasized that data privacy assurances were a critical factor for their adoption of AI-driven healthcare tools. This highlights that clinical effectiveness alone is insufficient without rigorous security measures. As a result, market growth is constrained by the imperative to earn practitioner trust through extensive and costly compliance verification.

Market Trends

The integration of Virtual Reality (VR) for Exposure Therapy is revolutionizing clinical treatment protocols by enabling practitioners to create controlled, immersive environments for patients struggling with PTSD, anxiety, and phobias. Unlike traditional talk therapy, this technology facilitates safe, gradual exposure to traumatic stimuli, significantly boosting patient engagement and retention rates through gamified rehabilitation exercises. This modality is rapidly transitioning from experimental pilots to widespread institutional adoption as healthcare providers acknowledge its effectiveness in delivering standardized, replicable care. The 'XR Health Landscape' report by the XR Health Alliance in October 2025 indicated that approximately 30% of NHS Trusts have already implemented extended reality solutions to enhance therapeutic delivery, signaling a robust shift towards immersive digital interventions within public health systems.The convergence of digital mental health solutions with corporate wellness programs is establishing employers as a key commercial channel for mental health platforms, fundamentally altering the market's revenue generation mechanisms. Organizations are proactively integrating digital therapeutic tools into employee benefit schemes to mitigate productivity losses associated with burnout and to reduce long-term healthcare expenditures. This trend emphasizes preventative care and resilience training, shifting the focus from treating acute conditions to maintaining continuous psychological well-being across the workforce. The '2025 Employer Well-being Strategy Survey' by the Business Group on Health in May 2025 found that 93% of surveyed global employers affirmed their plans to maintain or expand their well-being offerings, solidifying the corporate sector's role as a critical financier of emerging mental health technologies.

Key Market Players

• Electromedical Products International, Inc
• Ginger Group Ltd.
• Happify Health
• Headspace Inc.
• Pear Therapeutics, Inc.
• Quartet Health
• Teladoc Health Inc.
• Woebot Health
• Clarigent Health
• Feel Therapeutics Inc.

Report Scope

In this report, the Global Emerging Mental Health Devices and Platforms Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Emerging Mental Health Devices and Platforms Market, By Type

• Platforms
• Devices

Emerging Mental Health Devices and Platforms Market, By Application

• Stress
• Anxiety
• Depression
• Bipolar Disorder
• Others

Emerging Mental Health Devices and Platforms Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Emerging Mental Health Devices and Platforms Market.

Available Customizations:

Global Emerging Mental Health Devices and Platforms Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Emerging Mental Health Devices and Platforms Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Platforms, Devices)
  • 5.2.2. By Application (Stress, Anxiety, Depression, Bipolar Disorder, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Emerging Mental Health Devices and Platforms Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Emerging Mental Health Devices and Platforms Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Emerging Mental Health Devices and Platforms Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Emerging Mental Health Devices and Platforms Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Emerging Mental Health Devices and Platforms Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Emerging Mental Health Devices and Platforms Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Emerging Mental Health Devices and Platforms Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Emerging Mental Health Devices and Platforms Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Emerging Mental Health Devices and Platforms Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Emerging Mental Health Devices and Platforms Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Emerging Mental Health Devices and Platforms Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Emerging Mental Health Devices and Platforms Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Emerging Mental Health Devices and Platforms Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Emerging Mental Health Devices and Platforms Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Emerging Mental Health Devices and Platforms Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Emerging Mental Health Devices and Platforms Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Emerging Mental Health Devices and Platforms Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Emerging Mental Health Devices and Platforms Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Emerging Mental Health Devices and Platforms Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Emerging Mental Health Devices and Platforms Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Emerging Mental Health Devices and Platforms Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Emerging Mental Health Devices and Platforms Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Emerging Mental Health Devices and Platforms Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Emerging Mental Health Devices and Platforms Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Emerging Mental Health Devices and Platforms Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Electromedical Products International, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Ginger Group Ltd.
• 15.3. Happify Health
• 15.4. Headspace Inc.
• 15.5. Pear Therapeutics, Inc.
• 15.6. Quartet Health
• 15.7. Teladoc Health Inc.
• 15.8. Woebot Health
• 15.9. Clarigent Health
• 15.10. Feel Therapeutics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer